Critical care
The selective pressure that results from inappropriate use of antibiotics highly correlates with the emergence of resistance. Appropriate antimicrobial stewardship incorporates the rapid identification and treatment of infections based on pharmacokinetic/pharmacodynamic properties, avoiding the use of needlessly broad spectrum agents, shortening the duration of administration and minimizing the number of patients receiving unnecessary antibiotics. Alongside the appropriate use of antibiotics the Surviving Sepsis Campaign emphasizes the importance of rapid source control. A diagnosis of infection amenable to rapid source control should be managed at the earliest opportunity and within critical care this not only includes identification of anatomical collections/infections but also removal of implantable devices such as intravascular and urinary catheters. Appropriate prescribing of antibiotic therapy in critical care would undoubtedly contribute towards reducing anti-
Key points
Although antibacterial resistance is growing, development of new antibiotics is in decline. Therefore strategies are needed to maintain the effectiveness of current antibiotics for as long as possible.
• Infections due to resistant organisms are associated with higher mortality, morbidity, longer hospital stays, and higher health care costs.
• An Antibiotic Stewardship Program is overseen by a multidisciplinary team consisting of clinicians, clinical pharmacists, and clinical microbiologists. Unusual infections may benefit from additional investigation and treatment advice from an infectious disease clinician and infection control specialists may provide advice relating to reducing spread.
• The key aims of antibiotic stewardship are to ensure the right drug is given at the right time, at the right dose and for the right duration, aiming to eradicate infection whilst minimizing collateral damage.
• Key components include: Prospective audit and feedback, antibiotic restriction, de-escalation, education, guideline use, optimal dosing and duration, microbiologist, and computer aided clinical support.
• Restrictive antibiotic policies are shown to improve antibiotic prescribing and resistance patterns. Antibiotic stewardship has not been shown to increase patient mortality, hospital length of stay or readmission.
Editorial decision 26 July 2016; Accepted: 20 September 2016 microbial resistance patterns, however the complexity of presentation and severity of illness in many patients makes rationalizing antibiotic therapy extremely challenging. The use of a formal Antibiotic Stewardship Program within critical care could therefore aid these difficult decisions.
Antibiotic resistance
The dramatic rise in carbapenem resistant Enterobacteriaceae is now a global concern. The lack of novel antibiotic development in recent years has kick started a global initiative from the IDSA (Infectious Disease Society of America) who aim to develop 10 new antibacterial drugs by 2020. 3 In critical care, the majority of infections are as a result of a small group of bacteria, which are becoming increasingly antibiotic resistant. This group has been given the acronym ESCAPE (Table 1) . 4 
Antibiotic stewardship in the NHS
Antibiotic stewardship is a hospital-wide practice that links infection control measures with judicious antibiotic management. Put simply, the aim is to administer the right drug at the right time, at the right dose, and for the right duration in order to eradicate infection whilst minimizing collateral damage such as nosocomial infection, drug toxicity, and the emergence of resistance and resultant escalating health care costs.
In 2007, the IDSA and the Society for Healthcare Epidemiology of America published a landmark paper describing the principles of an Antibiotic Stewardship Program. 5 The Department of Health and Public Health England introduced the 'Start Smart-Then Focus' Antibiotic Stewardship campaign and toolkit which provides a framework of both clinical and non-clinical interventions required for a robust Antibiotic Stewardship Program (Fig. 1) .
7 This is supported by NICE guidance. 8 The antibiotic stewardship multidisciplinary team 
Formulary restriction
• Formulary restriction, or the requirement of a numerical prescribing code is the most effective method of curtailing widespread use of specific antibiotics. Antibiotics may also be restricted by clinical area, specialty or seniority and commonly involve antibiotics with broad spectrum activity, those associated with rapid emergence of resistance or those with a risk of toxicity. The clear disadvantage of this intervention is the perceived loss of prescriber autonomy and potential delay in drug administration whilst approval is sought.
Evidence-based guidelines
• Multidisciplinary development of evidence-based guidelines incorporating local microbiology and resistance patterns can improve antimicrobial utilization. They should include diagnosis and treatment of common infections and surgical prophylaxis regimes. Guidelines should recommend empirical antibiotic dosing, route, duration and de-escalation regimes, monitoring advice, and contingency plans for treatment failure. The implementation of guidelines in critical care has been shown to reduce hospital length of stay, duration of mechanical ventilation, and the duration of antibiotic treatment. 9 Antibiotic optimization
• Prolonged courses of broad spectrum antibiotics are known to contribute to antibiotic resistance and de-escalation (or stopping antibiotics if infection is less likely) should be Antibiotic stewardship in critical care
considered at 48-72 h or as soon as culture sensitivities are available. A review by NICE has shown no evidence that deescalation at 48-72 h increases mortality, hospital, or critical care length of stay. 8 An alternative approach to using a broad-spectrum agent is to use a combination of narrowerspectrum agents exploiting antibiotic synergy, however the sensitivity of the organism is required for this approach and it may subject the patient to poly-pharmacy and toxic side effects without any reduction in antimicrobial resistance.
• Shortened courses of antibiotics have become typical UK practice in recent years supported by studies from Chastre et al. 10 who compared 8 vs 15 days of therapy for ventilator associated pneumonia in a randomized, multicentre trial. They demonstrated that a shorter duration of antibiotic treatment reduced the emergence of multi-resistant pathogens without adversely impacting on mortality, critical care length of stay, or mechanical ventilator-free days. Most critical care units now use white cell count and biochemical markers as well as an improving clinical picture to customize treatment duration and support shorter antibiotic courses.
• The conversion from parenteral to enteral antibiotic therapy should occur once clinically indicated and when reliable enteral absorption is assumed. Although the removal of venous access may reduce health care associated complications there is little evidence to suggest that oral antibiotics reduce the selection of resistant pathogens.
Dose optimization
• It is well recognized that sub-therapeutic antibiotic concentrations result in antibiotic resistance and treatment failure. Many antibiotics were originally dosed using healthy volunteers with little account made for the pharmacodynamic changes seen in the critically ill. Antibiotics can be challenging to dose in the context of critical illness where volume of distribution and drug clearance vary markedly on a day to day basis. Critical care pharmacists provide expert dosing guidance to ensure maximal efficacy whilst minimizing side effects.
• When considering antibiotic therapy it is important to consider the minimum inhibitory concentration (MIC). The MIC is the concentration of an antimicrobial required to completely inhibit microbe growth. Some antibiotics are consistently bactericidal when their concentration is above the MIC of the target organism (time-dependent) whilst others depend upon the peak concentration achieved at the infection site (concentration-dependent) (Fig. 3) .
• With time-dependent killing, the rate and extent of microbe killing remain unchanged regardless of how high antimicrobial concentration is, providing it is above the MIC. The pharmacodynamic parameter predictive of outcome is the time the concentration is above the MIC (T>MIC). To maximize timedependent activity, these antibiotics need to be administered regularly so that the antibiotic concentration is above the MIC for as long as possible (e.g. beta lactams). The use of extended antibiotic infusions has been shown to reduce treatment failure and critical care length of stay but has not been shown to impact on mortality.
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• With concentration-dependent killing, the rate and extent of microorganism killing are dependent on the antimicrobial concentration. The pharmacodynamic parameter predictive of outcome for concentration dependent drugs is the peak concentration (Cmax/MIC). These antibiotics are given at high doses at less frequent intervals. (e.g. aminoglycosides). Glycopeptides exhibit both concentration and time-dependent killing and the best predictor of efficacy is the AUC/MIC. Carbapenems show a marked post antibiotic effect where bacterial growth is suppressed at concentrations well below the MIC.
Education and training
• Education is the cornerstone of antibiotic stewardship with mandatory core training in antibiotic use for nurses, doctors, and pharmacists. Nursing staff should be aware of the importance of avoiding missed or delayed doses of antimicrobials and prompt collection of specimens. Nurses should also feel empowered to question the choice and duration of antibiotic prescriptions that contradict local guidelines. Dedicated teaching built into both undergraduate and postgraduate medical training should focus on the science behind resistance development and the principles of antibiotic stewardship. Pharmacists are integral to the success of stewardship programs through the provision of advice and education 'on the shop floor' and participating in guideline and formulary development, audit, and research.
Information technology and computer assisted support
• Health care information technology (IT) in the form of electronic medical records, electronic prescribing, and clinical decision support systems can enhance decision-making and patient safety. These systems can be designed to trigger 'drug-bug' mismatch alerts, liver and renal impairment dosing alterations, drug interaction, and allergy warnings. Although setting up IT systems can be costly, it has been shown to improve antibiotic prescribing and reduce overall health care costs. 12 However, additional training may be required for staff and some systems and their layouts may be difficult to interpret.
Microbiology laboratories
• The clinical microbiology laboratory plays a crucial role in antibiotic stewardship. Specific antibiograms identify local microbe resistance and sensitivity patterns and are used to develop antibiotic guidelines and 'police' antibiotic formularies. Blood cultures are still considered the gold standard to diagnose blood stream infections as they detect viable microorganisms that can be characterized by molecular or biochemical techniques. This process can incur significant delays and incomplete results are common. More recently, attention has been focused on the use of fully automated mass spectrometry and real-time polymerase chain reaction (PCR) for bacterial identification. Matrix Assisted Laser Desorption Ionization Time-Of-Flight (MALDI-TOF) uses ionization to analyse biomolecules and species diagnosis can be achieved within 4 h of a positive culture result. Advances in nucleic-acid based diagnostics can now detect microbes directly from blood samples without prior cultivation. Realtime PCR testing has been shown to significantly reduce organism identification time with excellent sensitivity and specificity. 13 Although these techniques involve significant investment in both equipment and training, they have been shown, in combination with an Antibiotic Stewardship Program, to reduce organism identification time, mortality, critical care length of stay, and bacteraemia recurrence. 14 
Leadership and teamwork
• Multidisciplinary team involvement is fundamental for effective antibiotic stewardship. The hospital management board holds ultimate responsibility and senior leadership is paramount to ensure all staff and managers are engaged and a coordinated approach is maintained throughout the hospital.
Review of the evidence
Davey et al. 15 conducted a Cochrane Review (2013) of interventions between 1980 and 2006 that were designed to improve antibiotic prescribing practices. Eighty-nine studies were reviewed and interventions were grouped as restrictive (formulary restriction), persuasive (audit, education, prescriber feedback, computer reminders), and structural (changing from paper to computer records, rapid laboratory testing). Outcome measures included antibiotic prescribing, microbial outcome (colonization with Clostridium difficile or other resistant organisms) and clinical outcome (mortality, length of stay and readmission). Davey showed that restrictive interventions were significantly superior in improving antibiotic prescribing and microbial resistance patterns. Many studies did not adequately report unintended consequences, which led to difficulty in assessing clinical outcome. Those reporting indicators of clinical outcome suggest that where interventions were made to improve effective prescribing and discourage excessive use of antimicrobials, there was no change in mortality, readmission rates, and hospital length of stay. Therefore although the evidence of improving clinical outcome is limited, it suggests that antibiotic stewardship leads to no harm. Wagner et al. 16 looked at 27 studies; 14 studies using audit/ feedback, 5 using formulary restriction, 4 using computerized decision support, and 4 implementing a policy/protocol intervention. All interventions showed little improvement in clinical outcome including mortality, length of stay, or readmission rates. However the use of formulary restriction and protocols resulted in more appropriate antimicrobial use and a reduction in C. difficile infection. Kaki et al. 9 reviewed critical care stewardship interventions conducted between 1996 and 2010 with 24 studies meeting the quality inclusion criteria. Six interventions were identified including antibiotic restriction, infectious diseases physician consultation, de-escalation guidelines, antibiotic reassessment on a pre-specified day, and implementation of computerassisted support. Antibiotic restriction interventions showed a statistically significant reduction in the prescribing of targeted antibiotics, however there was a compensatory 200-300% increase in use of other similar spectrum antibiotics. Computerassisted support, antibiotic reassessment, and infectious disease consultation showed a reduction in targeted therapy without such a compensatory prescribing pattern. Over half of the studies investigated bacterial resistance patterns and found that antibiotic restriction, de-escalation guidelines, and computer-assisted support had a significant effect in reducing many of the ESCAPE pathogens. Further review highlighted that antibiotic stewardship interventions were associated with reduction in antibiotic use and cost, shorter duration of therapy, less inappropriate use, and fewer antibiotic-related adverse events. Also there was no increase in the incidence of nosocomial infection rates, length of stay or mortality with the introduction of Antibiotic Stewardship Programs. Feazel et al. 17 conducted a systematic review and metaanalysis of studies between 1997 and 2013, looking at the effect of Antibiotic Stewardship Programs on C.difficile infection. Sixteen studies met the inclusion criteria and stewardship programs were separated into restrictive and persuasive interventions. The overall outcome showed a 52% risk reduction of C. difficile. Restrictive policies had a greater protective effect than persuasive policies. It is widely assumed that setting up an Antibiotic Stewardship Program will require considerable monetary investment. However a reduction in antibiotic use, reduced length of stay, and a reduction in antimicrobial resistance could offset this investment. Gray et al. 18 studied the economics of antibiotic stewardship showing that regular review of antibiotic prescriptions led to a significant number of patients having their antibiotic route of administration de-escalated, treatment stopped or an earlier discharge from hospital. This intervention was carried out by a microbiologist but whether a computerized system could yield the same results needs further research. It is difficult at ascertain whether this transfers health costs to primary care and the social sector, but a reduction in inpatient numbers will certainly reduce hospital acquired infection rates. With antibiotic resistance becoming a global health care crisis, this investment of local Antibiotic Stewardship Programs should be considered an international investment towards improved health care. In summary, the evidence suggests that the implementation of an Antibiotic Stewardship Program can reduce antimicrobial resistance, incidence of hospital-acquired infections, reduce inappropriate antibiotic use, and be cost effective. Even though there is little evidence to suggest improvement in clinical outcome, there is no evidence to suggest harm. The heterogeneity of interventions and study designs and the confounding effect of infection control interventions have made it difficult to reach any firm conclusion regarding individual stewardship interventions.
Future advances in antibiotic stewardship
As pathogens are isolated from only a minority of microbiological samples and often after a significant delay, the development of a biomarker that could accurately identify infection would greatly enhance effective antibiotic stewardship. More than 150 biomarkers have been tested as potential diagnostic and prognostic markers including pro-calcitonin (PCT). PCT is a precursor of calcitonin produced by C cells of the thyroid. It is released in the presence of infection and has been used as a Antibiotic stewardship in critical care marker to distinguish infection from inflammation, however as it has low specificity and sensitivity its use in regular practice is questionable. The PRORATA randomized controlled trial set out to establish the effectiveness of PCT guided antibiotic use and showed that it did reduce antibiotic exposure but did not affect mortality or impact on antibiotic resistance. 19 
Conclusion
Antibiotic Stewardship Programs provide a practical and manageable approach to the use of antibiotics within our health care system aiming to reduce antibiotic resistance and prolong their ability to continue fighting infection. The potential benefits to future health care are significant and the ultimate success of a stewardship program depends on interdisciplinary team working, education, and feedback.
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